We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Frequently Asked Questions

Doing Business With Us

Our Approach to Supplier Diversity

Products and Services We Purchase

How to Contact Us